Mann A, Boulanger T, Brandau B, Durant F, Evrard G, Heaulme M, Desaulles E, Wermuth C G
Centre de Neurochimie du CNRS, Département de Pharmacochimie Moléculaire, Strasbourg, France.
J Med Chem. 1991 Apr;34(4):1307-13. doi: 10.1021/jm00108a011.
The synthesis of six close analogues of baclofen [3-(4-chlorophenyl)-4-aminobutyric acid] (BAC), a potent GABAB agonist, are reported. The compounds were designed starting from the structural informations contained in the solid state of BAC, regarded as a possible bioactive conformation, in which the p-chlorophenyl ring is perpendicular to the GABA backbone. A similar conformational situation was created by rigidifying the BAC structure by means of methylene (1), ethylene (2 and 6), or propylene (3) units, or by introducing chlorine atoms (4 and 5) into the ortho positions ("ortho effect"). Only compound 5 showed affinity for the GABAB receptor. Compound 6 [1-(aminomethyl)-5-chloro-2,3-dihydro-1H-indene-1-acetic acid], which was initially considered as representing the optimal mimic of the solid-state conformation of BAC, was surprisingly found inactive. An extensive conformational analysis was performed on compounds 1-6 in order to evaluate their flexibility and the overlap of their conformational population with respect to BAC. For this purpose a distance map was generated from three possible pharmacophoric groups: the amino and the carboxylic functions, and the phenyl ring. Finally, several explanations are proposed to account for the poor affinities of the prepared compounds such as steric hindrance or flexibility demand of the receptor.
本文报道了强效GABAB激动剂巴氯芬3-(4-氯苯基)-4-氨基丁酸六种紧密类似物的合成。这些化合物是根据BAC固态中所含的结构信息设计的,该结构被视为一种可能的生物活性构象,其中对氯苯基环垂直于GABA主链。通过亚甲基(1)、乙烯(2和6)或丙烯(3)单元使BAC结构刚性化,或通过在邻位引入氯原子(4和5)("邻位效应")来创造类似的构象情况。只有化合物5对GABAB受体表现出亲和力。化合物6[1-(氨基甲基)-5-氯-2,3-二氢-1H-茚-1-乙酸]最初被认为是BAC固态构象的最佳模拟物,但令人惊讶的是发现其无活性。对化合物1-6进行了广泛的构象分析,以评估它们的灵活性以及它们的构象群体与BAC的重叠情况。为此,从三个可能的药效基团生成了距离图:氨基和羧基官能团以及苯环。最后,提出了几种解释来解释所制备化合物亲和力差的原因,如空间位阻或受体的灵活性需求。